Recent progress in induced pluripotent stem cell-derived 3D cultures for cardiac regeneration.
Cardiovascular diseases are the leading cause of death in the world due to the high incidence of the diseases coupled with the limited therapeutic options. In recent years, advances in regenerative medicine have emerged as a promising treatment. Differentiation of induced pluripotent stem cells (iPSCs) into cardiac cells and emerging technologies allowing arrangement of cells into complex 3D tissue-like structures open new frontiers for transplantation and engraftment of these tissue patches onto the damaged heart. Despite the cells integrating and presenting initial neovascularization, the functional and electric properties of these patches are still not comparable with those of the host cardiac tissue. Future research optimizing maturation and integration of the iPSC-derived cardiomyocytes is paramount for cardiac cell therapy to attain clinical use. Herein, we will review the state of the art and the different approaches to constructing these 3D transplantable structures.
['Wang|Kai-Li|KL|', 'Xue|Qi|Q|', 'Xu|Xun-Hong|XH|', 'Hu|Fang|F|', 'Shao|Hong|H|http://orcid.org/0000-0002-0129-6945']
D002454:Cell Differentiation D048091:Guided Tissue Regeneration D006801:Humans D021621:Imaging, Three-Dimensional D057026:Induced Pluripotent Stem Cells D032383:Myocytes, Cardiac D023822:Tissue Engineering
Induced pluripotent stem cells iPSC-derived cardiomyocytes 3D bioprinting Cardiac regenerative medicine Cell sheets Tissue engineering